menopause, Dunaif said. And last month, the agency approved Vyleesi (bremelanotide), an injectable drug, for the same purpose.
In this new environment, Davis and her colleagues returned to the potential of testosterone therapy for women, analyzing a set of clinical trials stretching between 1990 and 2018. The work was funded by the Australian National Health and Medical Research Council.
The pooled data showed that topical testosterone therapy, by gel or patch, could improve older women’s sex lives by about one additional satisfying sexual encounter each month.
That might not sound like a lot, but women’s health expert Dr. Holly Thacker argued that it is a huge difference.
“It is a lot because if you’re having sex once a week for duty sex and you don’t enjoy it or want it, and then you go from having duty sex four times a month to maybe five or six times a month and really